AbbVie Inc (ABBV)

Payables turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Cost of revenue (ttm) US$ in thousands 14,866,000 12,856,000 15,129,000 17,193,000 17,097,000 18,881,000 17,418,000 17,348,000 17,414,000 17,564,000 16,932,000 17,285,000 17,446,000 17,810,000 18,470,000 17,658,000 15,387,000 12,709,000 9,579,000 7,687,000
Payables US$ in thousands
Payables turnover

December 31, 2024 calculation

Payables turnover = Cost of revenue (ttm) ÷ Payables
= $14,866,000K ÷ $—K
= —

Based on the provided data, the payable turnover ratio for AbbVie Inc is not available or provided as "—". This implies that details needed to calculate the payables turnover ratio are missing for all the specified dates.

Without the specific payables and cost of goods sold (COGS) figures, we are unable to compute the payable turnover ratio. The payables turnover ratio is a financial metric that assesses how efficiently a company is managing its payable accounts by measuring the number of times a company pays off its average accounts payable balance in a given period. A higher payables turnover ratio typically indicates that the company is paying its suppliers more frequently, which could suggest better liquidity or more favorable credit terms.

As no data is available for the payables turnover ratio, it is difficult to provide a detailed analysis of AbbVie Inc's payables management efficiency over the specified periods. It would be beneficial to obtain the necessary financial data to compute this ratio in order to assess AbbVie Inc's ability to manage its accounts payable effectively.


See also:

AbbVie Inc Payables Turnover (Quarterly Data)